. 2011 Nov 30;36(5):1051–1058. doi: 10.1007/s00264-011-1410-8

Table 2.

Pain assessment of PHILOS and LPHP treated patients categorized according to Neer fracture type

Follow-up	Treatment	Pain at fracture site^a		%	RR	95%CI	P-value^b
Follow-up	Treatment	No	Yes	%	RR	95%CI	P-value^b
2-part fractures
Three months	LPHP	9	30	77%
Three months	PHILOS	21	20	49%	0.65	(0.45;0.93)	0.019
Six months	LPHP	9	29	76%
Six months	PHILOS	21	16	43%	0.59	(0.39;0.89)	0.012
One year	LPHP	15	20	57%
One year	PHILOS	28	15	35%	0.44	(0.24;0.82)	0.009
3-part fractures
Three months	LPHP	21	56	73%
Three months	PHILOS	24	39	62%	0.93	(0.72;1.2)	0.574
Six months	LPHP	29	40	58%
Six months	PHILOS	31	29	48%	0.67	(0.48;0.93)	0.017
One year	LPHP	37	33	47%
One year	PHILOS	38	21	36%	0.54	(0.37;0.79)	0.001
4-part fractures
Three months	LPHP	6	27	82%
Three months	PHILOS	19	12	39%	0.42	(0.26;0.67)	<0.001
Six months	LPHP	12	23	66%
Six months	PHILOS	19	10	34%	0.42	(0.25;0.71)	0.001
One year	LPHP	14	19	58%
One year	PHILOS	20	13	39%	0.67	(0.38;1.16)	0.152

PHILOS proximal humeral interlocking system, LPHP locking proximal humerus plate, CI confidence interval, RR adjusted relative risk

n corresponds to the actual number of patients with follow-up data at the nominated time point

^a Assessed according to the Constant score pain component

^b Based on the Wald test